Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 144,646 $ 193,598
Accounts receivable, net 223,827 193,875
Inventory, net 43,186 39,681
Other current assets and prepaid expenses 90,408 26,904
Total current assets 502,067 454,058
Property, plant and equipment, net 125,486 131,798
Intangible assets, net 781,890 638,152
In-process research and development 646,970 792,275
Goodwill 700,526 743,348
Investments 38,783 34,716
Other assets 4,305 4,841
Total assets 2,800,027 2,799,188
Current liabilities:    
Accounts payable 58,544 72,535
Accrued expenses 186,076 167,899
Current portion of lines of credit and notes payable 9,891 11,468
Total current liabilities 254,511 251,902
2033 Senior Notes and estimated fair value of embedded derivatives, net of discount 51,537 48,986
Deferred tax liabilities, net 184,493  
Deferred tax liabilities, net   226,036
Other long-term liabilities, principally deferred revenue and line of credit 204,094 292,470
Total long-term liabilities 440,124 567,492
Total liabilities 694,635 819,394
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 558,053,479 and 546,188,516 shares issued at September 30, 2016 and December 31, 2015, respectively 5,581 5,462
Treasury Stock - 586,760 and 1,120,367 shares at September 30, 2016 and December 31, 2015, respectively (1,911) (3,645)
Additional paid-in capital 2,834,300 2,705,385
Accumulated other comprehensive loss (16,284) (22,537)
Accumulated deficit (716,294) (704,871)
Total shareholders’ equity 2,105,392 1,979,794
Total liabilities and equity $ 2,800,027 $ 2,799,188